VitalWare completes financing to spur growth of revenue cycle solutions: 4 things to know


VitalWare, a provider of revenue cycle SaaS solutions to healthcare organizations, has received investment funding from F-Prime Capital Partners, formerly Fidelity Biosciences, a global venture capital firm investing in healthcare and technology.

Here are four things to know about the funding.

1. F-Prime Capital was the only institutional investor in the Series A financing.

2. Kerry Martin, president and CEO of VitalWare, spoke positively of the funding, saying it "helps us [the company] to continue investing in future technology, sales and marketing and talent to provide the best healthcare revenue cycle solutions available in the industry."

3. The amount of funding was not disclosed.

4. Following the investment, F-Prime partners Jon Lim and Carl Byers have joined the VitalWare board of directors.

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Whitepapers

Featured Webinars